1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Becton, Dickinson And Co.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
Thomas Polen

1 Becton Dr
Franklin Lakes, New Jersey 07417-1815
Phone: 12018476800


Becton Dickinson exec sells $71.8k in company stock
Jun 11, 2024 17:48pm
Medical-technology company Becton Dickinson agreed to acquire Edwards Lifesciences'' Critical Care product group for $4.2 billion, increasing its access to hospital customers.
Jun 04, 2024 04:01am

Medical-technology company Becton Dickinson agreed to acquire Edwards Lifesciences’ Critical Care product group for $4.2 billion, increasing its access to hospital customers.

Source:The Wall Street Journal
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences'' Critical Care Group: Details
Jun 03, 2024 16:02pm

Shares of medical technology company Becton, Dickinson And Company (NYSE: BDX ) are trading higher after the company said it will acquire Edwards Lifesciences Corp’s (NYSE: EW ) Critical Care product group, an advanced monitoring solutions provider, for $4.2 billion in cash. Critical Care has approximately 4,500 employees, most of whom are based in Irvine, California. In 2023, the business generated more than $900 million in revenue. This acquisition is set to enhance BD’s portfolio in smart connected care solutions, providing significant value creation opportunities. The transaction is expected to be immediately accretive to all key financial measures, including revenue growth, adjusted gross and operating margins, and adjusted earnings per share. Critical Care, serves millions of patients worldwide with its … Full story available on

STAT+: Becton Dickinson to buy Edwards patient monitoring unit for $4.2 billion
Jun 03, 2024 15:30pm

Becton Dickinson, BD, plans to buy Edwards Lifesciences patient monitoring business for $4.2 billion, the companies announced Monday.

Source:STAT News
Mondays rapid-fire: WM, Becton Dickinson, Boston Beer, Paramount, Spotify
Jun 03, 2024 15:09pm

Jim Cramer looks at five stocks outside the CNBC Investing Clubs portfolio.

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
Jun 03, 2024 13:25pm

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson''s plan to buy a key division for $4.2 billion.

Source:Investor''s Business Daily
M&A News: BDX Snaps Up Edwards Life’s Critical Care Unit in $4.2B Deal
Jun 03, 2024 13:16pm

Medical technology giant Becton, Dickinson, and Co. (NYSE:BDX) is snapping up Edwards Lifesciences’ (NYSE:EW) critical care unit in a $4.2 billion …

Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
Jun 03, 2024 11:43am

Edwards Lifesciences on Monday said it has agreed to sell its Critical Care products unit to Becton Dickinson in an all-cash transaction valued at $4.2 billion.

Becton Dickinson to Acquire Edwards Lifesciences'' Unit for $4.2B in Cash
Jun 03, 2024 11:15am

Becton Dickinson agreed to acquire an Edwards Lifesciences unit for $4.2 billion in cash, putting it near the top of its many M&A deals.

Source:The Wall Street Journal
Edwards Lifesciences Stock Up With BD Deal To Buy Critical Care Product Unit For $4.2 Bln Cash
Jun 03, 2024 10:55am

Medical technology company Becton, Dickinson and Co. (BDX) announced Monday a definitive agreement to acquire Edwards Lifesciences'' (EW) Critical Care product group for $4.2 billion in cash.

Source:RTT News